Photo from wikipedia
Lipocalin‐2 (LCN2) is an acute‐phase protein that could mediate neuroinflammation after brain injury. We aimed to evaluate if LCN2 level was associated with early neurological deterioration (END) in acute ischemic… Click to show full abstract
Lipocalin‐2 (LCN2) is an acute‐phase protein that could mediate neuroinflammation after brain injury. We aimed to evaluate if LCN2 level was associated with early neurological deterioration (END) in acute ischemic stroke patients, thus hindering clinical recovery.
Keywords:
neurological deterioration;
early neurological;
acute ischemic;
ischemic stroke
Journal Title: Brain and Behavior
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!